FindTrial
Sign In

A study comparing holmium laser enucleation with plasmakinetic enucleation of the prostate for benign prostatic hyperplasia.

A study comparing holmium laser enucleation with plasmakinetic enucleation of the prostate for benign prostatic hyperplasia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004468
Enrollment
Unknown
Registered
2013-08-06
Start date
2014-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

holep:holep surgery
PKEP:PKEP surgery

Sponsors

Shanghai Ninth People Hospital affiliated to Shanghai JiaoTong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
51 Years to 96 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for the study were indications for the surgical treatment of BPH.

Exclusion criteria

Exclusion criteria: Patients with severe pulmonary disease or heart disease, bladder calculus, neurogenic bladder dysfunction, bladder cancer, previous prostate surgery, prostate cancer, urethral stricture or coagulopathy were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Qmax;IPSS score;QOL score;—

Countries

China

Contacts

Public ContactZhong Wang

Shanghai Ninth People’s Hospital Affiliated Shanghai Jiaotong University School of Medicine

zhongwang2010@sina.com+86 13301980998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026